Filter
302
Filtered Results: 302
Text search:
patients
séropositifs
Featured
Recommendations
23
New Publications
68
Language
Document type
No document type
195
Guidelines
44
Studies & Reports
37
Manuals
8
Fact sheets
6
Strategic & Response Plan
3
Training Material
2
Brochures
2
Situation Updates
2
Resource Platforms
2
Infographics
1
Countries / Regions
Congo, Democratic Republic of
13
Global
9
Benin
8
Cameroon
8
Senegal
7
Tanzania
7
India
6
Nepal
5
Kenya
5
Burkina Faso
5
Philippines
5
Africa
5
Western and Central Europe
5
Colombia
4
Haiti
4
Latin America and the Carribbean
4
South Africa
4
Eastern Europe
4
Brazil
4
Zambia
4
Madagascar
4
Ukraine
3
Nigeria
3
Malawi
3
Bangladesh
3
Ethiopia
3
Sierra Leone
2
Rwanda
2
Albania
2
Mozambique
2
Cambodia
2
Germany
2
West and Central Africa
2
East and Southern Africa
2
Russia
2
Myanmar / Burma
2
Pakistan
2
Lesotho
1
Turkey
1
Syria
1
Iran
1
Morocco
1
Guinea
1
USA
1
Asia
1
Jordan
1
Saudi Arabia
1
Middle East and North Africa
1
Tunisia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Lebanon
1
Namibia
1
Sudan
1
Greece
1
Georgia
1
Central African Republic
1
Poland
1
Mali
1
Iraq
1
Ecuador
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
35
Women & Child Health
7
Public Health
6
Capacity Building
4
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
HIV
55
TB
42
NTDs
33
COVID-19
22
Mental Health
7
Ebola & Marburg
7
Rapid Response
6
Refugee
4
Polio
4
Disability
2
Caregiver
2
Health Financing Toolbox
2
Cholera
1
Planetary Health
1
Pharmacy
1
Conflict
1
Global Health Education
1
Le présent document s’adresse essentiellement au personnel des programmes de surveillance du VIH dont la tâche est de surveiller l’évolution de l’épidémie de VIH. Il décrit la manière dont les données recueillies systématiquement dans le cadre des programmes de prévention de la trans...
Les documents d’orientation sont révisés en fonction de l’évolution permanente
de la recherche. Les énoncés des compétences essentielles de l’ICM sont également évalués et modifiés au fur et à mesure que des preuves pertinentes concernant les soins de santé sexuelle, génésique, ...
Informations sur le VIH/SIDA
Accessed: 08.11.2020
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Considerando los cambios estratégicos en el abordaje de la salud pública y de la atención primaria de la salud, la prevención y el control de la tuberculosis en Ecuador genera un cambio en la parte organizacional y en la prestación de servicios con enfoque en grupos vulnerables y/o con factores...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
The objective of the EMTCT Plus initiative is to achieve and sustain the elimination
of mother-to-child transmission of HIV, syphilis, Chagas, and perinatal hepatitis
B (HBV) as a public health threat. It embraces the principles and lines of action
of the Strategy for Universal Access to Health a...
Workplaces outside of healthcare facilities can be also settings for transmission of COVID-19. Outbreaks of COVID-19 has been reported in various types of workplaces and job categories.
All workers should be protected from acquiring COVID-19 because of their work. The prevention of COVID-19 in ...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Pre-Publication draft version. Lat reviewed on 7th July 2017
